Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Ann Thorac Surg. 2010 Oct;90(4):1202–1211. doi: 10.1016/j.athoracsur.2010.05.018

Table 2.

Characteristics for Patients Undergoing Mitral Valve Replacementa

Variable No PPM (n = 372) Moderate PPM (n = 286) Severe PPM (n = 107) p Value
Age (y) 60 ± 15 62 ± 14 65 ± 13 0.01
Patients <65 y 205 (55%) 146 (51%) 44 (41%) 0.04
Body surface area (m2) 1.76 ± 0.20 1.95 ± 0.23 1.97 ± 0.31 <0.001
Diabetes mellitus 57 (15%) 75 (26%) 45 (42%) <0.001
Chronic renal disease 47 (13%) 38 (13%) 26 (24%) 0.008
Ejection fraction 0.47 ± 0.13 0.48 ± 0.13 0.47 ± 0.14 0.31
Emergent/urgent status 49 (13%) 35 (12%) 16 (15%) 0.77
Endocarditis 62 (17%) 47 (16%) 31 (29%) 0.009
Bioprosthetic valve implanted 82 (22%) 146 (51%) 97 (91%) <0.001
Pulmonary hypertensionb 178/290 (61%) 156/246 (63%) 66/99 (67%) 0.66
a

Continuous variables are mean ± standard deviation. Groups were compared using analysis of variance or χ2 test as appropriate. Probability values refer to the comparison among all three groups.

b

Not collected before 1996.

PPM = prosthesis-patient mismatch.